Jeff Rosenbaum is a Co-Founder and Partner at Dovetail Consulting Group. Jeff brings a unique approach to his client engagements—partnering with pharmaceutical and biotechnology companies to bring deep real-world experience coupled with structured consulting discipline to provide pragmatic and realistic solutions.
Before founding Dovetail Consulting Group, Jeff was the Chief Compliance and Risk Officer at Shire. He was responsible for the company’s Global Compliance and Risk Management function, including Corporate and Healthcare Compliance; Privacy; Employee, Health, and Safety (EHS); Corporate Security; and Enterprise Risk Management (ERM).
Prior to joining Shire, Jeff was responsible for developing, implementing, and monitoring global compliance programs, first at Novartis Oncology as the Global Head of Ethics & Compliance, and then at Vertex Pharmaceuticals, where he was the Chief Compliance Officer.
Earlier in his career, Jeff was a Director in Global Pharmaceutical Advisory Practice at PricewaterhouseCoopers. While there, he advised pharmaceutical, biotechnology, and medical device companies regarding matters of corporate governance, non-financial risk, and regulatory compliance.
Jeff began his career in the pharmaceutical industry at Wyeth Pharmaceuticals, where he worked in product marketing, business development, and field sales. Jeff holds an M.B.A. from the University of Virginia’s Darden School of Business and a B.A. from the University of Pennsylvania